The Hindu Business Line : Nicholas Piramal, IISc pact for drug research

PHARMA major Nicholas Piramal India Ltd (NPIL) has entered into a research collaboration with the Bangalore-based Indian Institute of Science (IISc) to identify potential new targets for developing drugs to treat fungal infections.

Meanwhile, the company has also appointed Dr Maneesh Nerurkar, as the in-charge of NPIL's formulations group that includes the New Drug Delivery Systems (NDDS) division.

On the collaboration with IISc, an NPIL communiqué said that Dr Parag Sadhale of the IISc' Department of Microbiology and Cell Biology would spearhead the collaborative effort. NPIL would have exclusive rights to commercialise any products coming out of this collaboration.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Orchid Chemicals gets European nod

Shreya Life targets Rs 500-cr turnover by March 2005

Friends Globe plans to open doors in South

To strike partnerships with other professionals — ICSI Council gives nod for members

Renaissance's Dalmia picks up stake in Lakshmi Vilas Bank

CESC to seek shareholders' nod in subsidiary merger

Ambuja Cement shelves expansion plans till June

A novel protest

Nicholas Piramal, IISc pact for drug research

Netafim India eyeing for partners in sprinklers, PVC — To gain from micro irrigation projects

A successful innings at Ernst &Young